Vitamin D and cognition in the elderly;Vitamine D et cognition chez le sujet âgé

Psychologie et NeuroPsychiatrie du Vieillissement

Volumn 8, Issue 4, 2010, Pages 255-262

  Constans, Thierry ^a   Mondon, Karl ^b   Annweller, Cédric ^c   Chavanne, Dominique ^a   Hommet, Caroune ^a,b  

^a CHU BRETONNEAU   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

^c UNIVERSITÉ D'ANGERS   (France)

Author keywords

Alzheimer's disease; Cognitive function; Dementia; Elderly people; Vitamin D

Indexed keywords

VITAMIN; VITAMIN D;

ADULT; AGED; ALZHEIMER DISEASE; COGNITION; COGNITIVE DEFECT; DIET SUPPLEMENTATION; HUMAN; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW; VITAMIN D DEFICIENCY;

ADULT; AGED; ALZHEIMER DISEASE; COGNITION; COGNITION DISORDERS; DIETARY SUPPLEMENTS; HUMANS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 78650836854     PISSN: 17601703     EISSN: 19506988     Source Type: Journal    
DOI: 10.1684/pnv.2010.0233     Document Type: Article

References (34)

1. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, et al. Effect of Vitamin D on falls : a meta-analysis. JAMA 2004; 291: 1999-2006.
2. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
3. Standing Committee on the scientific evaluation of dietary reference intakes FaNB, Institute of medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride. Washington, DC : National Academy Press, 1999.
4. Martin A. Apports nutritionnels conseillés pour la population française. In : Afssa, Cnerma, CNRS, eds. Vol. 3. Paris : Tec & Doc, 2001.
5. Vieth R. Why the optimal requirement for vitamin D3 is probably much higher than what is officially recommended for adults? J Steroid Biochem Mol Biol 2004 ; 89-90: 575-9.
6. Constans T, Deschasse G, Chavanne D. Indications et modalités de prescription de la vitamine D et du calcium. Cahiers de l'Année Gérontologique 2009; 1:1-5.
7. McCann JC, Ames BN. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction ? FASEBJ J 2008 ; 22: 982-1001.
8. Fierro L, Llano I. High endogenous calcium buffering in Purkinje cells from rat cerebellar slices. J Physiol 1996 ; 496: 617-25.
9. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005 ; 29: 21-30.
10. Musiol IM, Stumpf WE, Bidmon HJ, Heiss C, Mayerhofer A, Bartke A. Vitamin D nuclear binding to neurons of the septal, substriatal and amygdaloid area in the Siberian hamster (Phodopus sungorus) brain. Neuroscience 1992 ; 48: 841-8.
11. Brown J, Bianco Jl, McGrath JJ, Eyles DW. 1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neunte outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett 2003 ; 343: 139-43.
12. Yamauchi T. Neuronal Ca2+/calmodulin-dependent protein kinase II-discovery, progress in a quarter of a century, and perspective : implication for learning and memory. Biol Pharm Bull 2005 ; 28: 1342-54.
13. Ibi M, Sawada H, Nakanishi M, Kume T, Katsuki H, Kaneko S, etal. Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology2001 ; 40: 761-71.
14. Brewer LD, Porter NM, Kerr DS, Landfield PW, Thibault O. Chronic 1 alpha,25-(OH)2 vitamin D3 treatment reduces Ca2+ -mediated hippocampal biomarkers of aging. Cell Calcium 2006 ; 40:277-86.
15. Stio M, Lunghi B, lantomasi T, Vincenzini MT, Treves C. Effect of vitamin D deficiency and 1,25-dihydroxyvitamin D3 on metabolism and D-glucose transport in rat cerebral cortex. J Neurosci Res 1993; 35: 559-66.
16. Lefebvre d'Hellencourt C, Montero-Menei CN, Bernard R, Couez D. Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line. J Neurosci Res 2003; 71: 575-82.
17. Moore ME, Piazza A, McCartney Y, Lynch MA. Evidence that vitamin D3 reverses age-related inflammatory changes in the rat hippocampus. Biochem Soc Trans 2005 ; 33: 573-7.
18. Sutherland MK, Somerville MJ, Yoong LK, Bergeron C, Haussler MR, McLachlan DR. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus : correlation with calbindin-28k mRNA levels. Brain Res Mol Brain Res 1992 ; 13: 239-50.
19. Jorde R, Waterloo K, Saleh F, Haug E, Svartberg J. Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromso study. J Neurol 2006 ; 253: 464-70.
20. Lee DM, Tajar A, Ulubaev A, Pendleton N, O'Neill TW, O'Connor DB, et al. Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J Neurol Neurosurg Psychiatry 2009 ; 80: 722-9.
21. Llewellyn DJ, Langa KM, Lang IA. Serum 25-hydroxyvitamin D concentration and cognitive impairment. J Geriatr Psychiatry Neurol 2009 ; 22: 188-95.
22. Annweiler C, Schott AM, Allali G, Bridenbaugh SA Kressing RW, Al lain P, et al. Association of vitamin D deficiency with cognitive impairment in older women. Cross-sectional study. Neurology 2010; 74: 27-32.
23. Oudshoorn C, Mattace-Raso FU, van der Velde N, Colin EM, van der Cammen TJ. Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2008 ; 25: 539-43.
24. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 2006; 14: 1032-40.
25. Buell JS, Scott TM, Dawson-Hughes B, Dallai GE, Rosenberg IH, Folstein MF, et al. Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci 2009 ; 64: 888-95.
26. McGrath J, Scragg R, Chant D, Eyles D, Bume T, Obradovic D. No association between serum 25-hydroxyvitamin D3 level and performance on psychometric tests in NHANES III. Neuroepidemiology 2007 ; 29: 49-54.
27. Slinin Y, Paudel ML, Taylor BC, Fink HA, Ishani A, Canales MT, et al. 25-hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology 2010 ; 74: 33-41.
28. Buell JS, Dawson-Hughes B, Scott TM, Weiner DE, Dallai GE, Qui WQ, et al. 25-hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 2010 ; 74:18-26.
29. Przybelski RJ, Binkley NC. Is vitamin D important for preserving cognition ? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys 2007 ; 460: 202-5.
30. Wilkins CH, Birge SJ, Sheline YI, Morris JC. Vitamin D deficiency is associated with worse cognitive performance and lower bone density in older African Americans. J Natl Med Assoc 2009 ; 101:349-54.
31. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005; 16:713-6.
32. Grant WB. Does vitamin D reduce the risk of dementia ? J Alzheimers Dis 2009 ; 17: 151-9.
33. Potischman N, Weed DL Causal criteria in nutritional epidemiology. Am J Clin Nutr 1999 ; 69: 1309S-1314S.
34. Gezen-Ak D, Dursun E, Ertan T, Hanagasi H, Guruit H, Emre M, et al. Association between vitamin D receptor gene polymorphism and Alzheimer's disease. Tohoku J Exp Med 2007 ; 212: 275-82.